Find up-to-date information on the trial cohorts open and closed to recruitment
OCTAVE Cohorts open to recruitment:
Deep Immunophenotyping Group (150 patients per cohort)
Rheumatic/Inflammatory conditions
Rheumatic, liver and renal conditions are closed
Cancer
Chronic liver conditions (including organ transplant) and inflammatory bowel disease
Chronic renal conditions (including organ transplant)
Haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T recipients
Serology Group (850 patient per cohort)
Rheumatic/Inflammatory conditions
Cancer
Chronic liver conditions (including organ transplant) and inflammatory bowel disease
Chronic renal conditions (including organ transplant)
Haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T recipients
Renal conditions is closed